{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:13:34Z","timestamp":1791825214062,"version":"4.3.4"},"reference-count":43,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,4,4]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>CLL cells induce defects in T-cell LFA-1\u2013mediated migration by altering Rho GTPase activation signaling, downregulating RhoA and Rac1, and upregulating Cdc42. Lenalidomide repairs these T-cell defects by restoring normal Rho GTPase activation signaling.<\/jats:p>","DOI":"10.1182\/blood-2012-08-448332","type":"journal-article","created":{"date-parts":[[2013,1,17]],"date-time":"2013-01-17T05:22:12Z","timestamp":1358400132000},"page":"2704-2714","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":119,"title":["Chronic lymphocytic leukemia cells induce defective LFA-1\u2013directed T-cell motility by altering Rho GTPase signaling that is reversible with lenalidomide"],"prefix":"10.1182","volume":"121","author":[{"given":"Alan G.","family":"Ramsay","sequence":"first","affiliation":[{"name":"Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Evans","sequence":"additional","affiliation":[{"name":"Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahryar","family":"Kiaii","sequence":"additional","affiliation":[{"name":"Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Svensson","sequence":"additional","affiliation":[{"name":"Leukocyte Adhesion Laboratory, Cancer Research UK, London Research Institute, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Hogg","sequence":"additional","affiliation":[{"name":"Leukocyte Adhesion Laboratory, Cancer Research UK, London Research Institute, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Gribben","sequence":"additional","affiliation":[{"name":"Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111809335945700_B1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1600-065X.2007.00537.x","article-title":"The role of the integrin LFA-1 in T-lymphocyte migration.","volume":"218","author":"Smith","year":"2007","journal-title":"Immunol Rev"},{"issue":"1","key":"2019111809335945700_B2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ceb.2011.10.004","article-title":"Integrin inside-out signaling and the immunological synapse.","volume":"24","author":"Springer","year":"2012","journal-title":"Curr Opin Cell Biol"},{"issue":"5","key":"2019111809335945700_B3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/ni1194","article-title":"Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium-bound chemokines.","volume":"6","author":"Shamri","year":"2005","journal-title":"Nat Immunol"},{"issue":"6","key":"2019111809335945700_B4","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nri2986","article-title":"The insider\u2019s guide to leukocyte integrin signalling and function.","volume":"11","author":"Hogg","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"2019111809335945700_B5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev.cellbio.21.090704.151217","article-title":"Integrin structure, allostery, and bidirectional signaling.","volume":"21","author":"Arnaout","year":"2005","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"2","key":"2019111809335945700_B6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nri2021","article-title":"Regulation of T-cell activation by the cytoskeleton.","volume":"7","author":"Billadeau","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"Pt 2","key":"2019111809335945700_B7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1242\/jcs.019117","article-title":"Integrins in immunity.","volume":"122","author":"Evans","year":"2009","journal-title":"J Cell Sci"},{"issue":"5","key":"2019111809335945700_B8","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation.","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"7378","key":"2019111809335945700_B9","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age.","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"issue":"1","key":"2019111809335945700_B10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrc2764","article-title":"From pathogenesis to treatment of chronic lymphocytic leukaemia.","volume":"10","author":"Zenz","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"2019111809335945700_B11","author":"Lanasa"},{"issue":"7","key":"2019111809335945700_B12","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1172\/JCI24176","article-title":"Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells.","volume":"115","author":"G\u00f6rg\u00fcn","year":"2005","journal-title":"J Clin Invest"},{"issue":"7","key":"2019111809335945700_B13","first-page":"2427","article-title":"Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug.","volume":"118","author":"Ramsay","year":"2008","journal-title":"J Clin Invest"},{"key":"2019111809335945700_B14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1034\/j.1600-065X.2002.18610.x","article-title":"The immunological synapse: integrins take the stage.","volume":"186","author":"Sims","year":"2002","journal-title":"Immunol Rev"},{"issue":"7","key":"2019111809335945700_B15","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1182\/blood-2012-02-411678","article-title":"Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer.","volume":"120","author":"Ramsay","year":"2012","journal-title":"Blood"},{"issue":"3","key":"2019111809335945700_B16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3109\/10428194.2011.618232","article-title":"Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia.","volume":"53","author":"Wendtner","year":"2012","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"2019111809335945700_B17","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1083\/jcb.116.6.1527","article-title":"Interaction of leukocyte integrins with ligand is necessary but not sufficient for function.","volume":"116","author":"Dransfield","year":"1992","journal-title":"J Cell Biol"},{"issue":"1","key":"2019111809335945700_B18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1083\/jcb.200412032","article-title":"A talin-dependent LFA-1 focal zone is formed by rapidly migrating T lymphocytes.","volume":"170","author":"Smith","year":"2005","journal-title":"J Cell Biol"},{"issue":"8","key":"2019111809335945700_B19","doi-asserted-by":"crossref","first-page":"e12393","DOI":"10.1371\/journal.pone.0012393","article-title":"Rac activation by the T-cell receptor inhibits T cell migration.","volume":"5","author":"Cernuda-Moroll\u00f3n","year":"2010","journal-title":"PLoS ONE"},{"issue":"Pt 15","key":"2019111809335945700_B20","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1242\/jcs.00606","article-title":"LFA-1-induced T cell migration on ICAM-1 involves regulation of MLCK-mediated attachment and ROCK-dependent detachment.","volume":"116","author":"Smith","year":"2003","journal-title":"J Cell Sci"},{"issue":"3","key":"2019111809335945700_B21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nm.1931","article-title":"Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation.","volume":"15","author":"Svensson","year":"2009","journal-title":"Nat Med"},{"issue":"8","key":"2019111809335945700_B22","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra041720","article-title":"Chronic lymphocytic leukemia.","volume":"352","author":"Chiorazzi","year":"2005","journal-title":"N Engl J Med"},{"issue":"9","key":"2019111809335945700_B23","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/sj.leu.2404802","article-title":"The role of prognostic factors in assessing \u2018high-risk\u2019 subgroups of patients with chronic lymphocytic leukemia.","volume":"21","author":"Kay","year":"2007","journal-title":"Leukemia"},{"issue":"5","key":"2019111809335945700_B24","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3324\/haematol.2009.013995","article-title":"CXCL12-induced chemotaxis is impaired in T cells from patients with ZAP-70-negative chronic lymphocytic leukemia.","volume":"95","author":"Borge","year":"2010","journal-title":"Haematologica"},{"issue":"9","key":"2019111809335945700_B25","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1200\/JCO.2010.29.8133","article-title":"Single-agent lenalidomide in the treatment of previously untreated chronic lymphocytic leukemia.","volume":"29","author":"Chen","year":"2011","journal-title":"J Clin Oncol"},{"issue":"12","key":"2019111809335945700_B26","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/leu.2011.165","article-title":"Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study.","volume":"25","author":"Nowakowski","year":"2011","journal-title":"Leukemia"},{"issue":"9","key":"2019111809335945700_B27","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3324\/haematol.2009.009274","article-title":"Immune dysfunction in chronic lymphocytic leukemia T cells and lenalidomide as an immunomodulatory drug.","volume":"94","author":"Ramsay","year":"2009","journal-title":"Haematologica"},{"issue":"11","key":"2019111809335945700_B28","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1038\/leu.2012.119","article-title":"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.","volume":"26","author":"Lopez-Girona","year":"2012","journal-title":"Leukemia"},{"key":"2019111809335945700_B29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1034\/j.1600-065X.2002.18613.x","article-title":"Integrin activation and structural rearrangement.","volume":"186","author":"Takagi","year":"2002","journal-title":"Immunol Rev"},{"issue":"9","key":"2019111809335945700_B30","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nri2606","article-title":"Rho family GTPases and their regulators in lymphocytes.","volume":"9","author":"Tybulewicz","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"1-2","key":"2019111809335945700_B31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2011.12.003","article-title":"Rho GTPases: masters of T lymphocyte migration and activation.","volume":"142","author":"Rougerie","year":"2012","journal-title":"Immunol Lett"},{"key":"2019111809335945700_B32","author":"Shanafelt"},{"issue":"2","key":"2019111809335945700_B33","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/ni.1691","article-title":"Regulation of conformer-specific activation of the integrin LFA-1 by a chemokine-triggered Rho signaling module.","volume":"10","author":"Bolomini-Vittori","year":"2009","journal-title":"Nat Immunol"},{"issue":"1","key":"2019111809335945700_B34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1074-7613(03)00350-9","article-title":"RhoA and zeta PKC control distinct modalities of LFA-1 activation by chemokines: critical role of LFA-1 affinity triggering in lymphocyte in vivo homing.","volume":"20","author":"Giagulli","year":"2004","journal-title":"Immunity"},{"issue":"4","key":"2019111809335945700_B35","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1083\/jcb.201002067","article-title":"Coordinated RhoA signaling at the leading edge and uropod is required for T cell transendothelial migration.","volume":"190","author":"Heasman","year":"2010","journal-title":"J Cell Biol"},{"issue":"7","key":"2019111809335945700_B36","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1128\/MCB.18.7.3936","article-title":"Rac regulates integrin-mediated spreading and increased adhesion of T lymphocytes.","volume":"18","author":"D\u2019Souza-Schorey","year":"1998","journal-title":"Mol Cell Biol"},{"issue":"6","key":"2019111809335945700_B37","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1189\/jlb.1001894","article-title":"Role of Rho-family GTPase Cdc42 in polarized expression of lymphocyte appendages.","volume":"73","author":"Ratner","year":"2003","journal-title":"J Leukoc Biol"},{"issue":"1","key":"2019111809335945700_B38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1084\/jem.20071543","article-title":"Nonmuscle myosin heavy chain IIA mediates integrin LFA-1 de-adhesion during T lymphocyte migration [published correction appears in J Exp Med. 2008;205(4):993.","volume":"205","author":"Morin","year":"2008","journal-title":"J Exp Med"},{"issue":"15","key":"2019111809335945700_B39","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1073\/pnas.0901166106","article-title":"E(mu)-TCL1 mice represent a model for immunotherapeutic reversal of chronic lymphocytic leukemia-induced T-cell dysfunction.","volume":"106","author":"Gorgun","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2019111809335945700_B40","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1182\/blood-2007-03-077628","article-title":"Essential role for Rap1 GTPase and its guanine exchange factor CalDAG-GEFI in LFA-1 but not VLA-4 integrin mediated human T-cell adhesion.","volume":"110","author":"Ghandour","year":"2007","journal-title":"Blood"},{"issue":"23","key":"2019111809335945700_B41","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1038\/emboj.2011.333","article-title":"Regulation of integrin affinity on cell surfaces.","volume":"30","author":"Sch\u00fcrpf","year":"2011","journal-title":"EMBO J"},{"issue":"12","key":"2019111809335945700_B42","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1182\/blood-2010-06-289140","article-title":"The integrin LFA-1 signals through ZAP-70 to regulate expression of high-affinity LFA-1 on T lymphocytes.","volume":"117","author":"Evans","year":"2011","journal-title":"Blood"},{"issue":"6","key":"2019111809335945700_B43","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.molcel.2008.11.018","article-title":"Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces.","volume":"32","author":"Zhu","year":"2008","journal-title":"Mol Cell"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/14\/2704\/1365440\/2704.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/14\/2704\/1365440\/2704.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T15:31:17Z","timestamp":1574091077000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/121\/14\/2704\/31146\/Chronic-lymphocytic-leukemia-cells-induce"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,4]]},"references-count":43,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2013,4,4]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-08-448332","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,4]]}}}